Mindy Lo PhD MD

Mindy Lo, MD, PhD

Assistant in Medicine

Instructor, Harvard Medical School

  • Contact: 617-355-6117

  • Fax: 617-730-0249

Medical Services

Specialties

  • Rheumatology
  • Systemic Lupus Erythematosus
  • Uvetitus

Departments

  • Rheumatology
  • Medicine

Programs

  • Rheumatology Program
To schedule an appointment: Call 617-355-6117

Experience and Education

Education

Graduate School

Washington University of St. Louis,

St. Louis, MO

Medical School

Washington University of St. Louis,

St. Louis, MO

Internship

Boston Children's Hospital,

Boston, MA

Residency

Boston Children's Hospital,

Boston, MA

Fellowship

Boston Children's Hospital,

Boston, MA

Publications

Publications powered by Harvard Catalyst
  1. Henderson LA, Volpi S, Frugoni F, Janssen E, Kim S, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Beth Son M, Mathieu R, Zurakowski D, Yu N, Lebedeva T, Fuhlbrigge RC, Walter JE, Nee Lee Y, Nigrovic PA, Notarangelo LD. Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2016 Jul; 68(7):1758-68.
  2. Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatr Rheumatol Online J. 2016; 14(1):9.
  3. Walter JE, Lo MS, Kis-Toth K, Tirosh I, Frugoni F, Lee YN, Csomos K, Chen K, Pillai S, Dunham J, Tsokos GC, Luning Prak ET, Notarangelo LD. Impaired receptor editing and heterozygous RAG2 mutation in a patient with systemic lupus erythematosus and erosive arthritis. J Allergy Clin Immunol. 2015 Jan; 135(1):272-3.
  4. Henderson LA, Zurakowski D, Angeles-Han S, Lasky A, Rabinovich CE, Lo MS. A70: medication use in the treatment of juvenile idiopathic uveitis patients enrolled in the childhood arthritis and rheumatology research alliance registry. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S102.
  5. Henderson LA, Volpi S, Frugoni F, Kim S, Janssen E, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Mathieu R, Fuhlbrigge RC, Lee YN, Nigrovic PA, Notarangelo LD. A119: deep sequencing analysis of the T regulatory and T effector repertoire in juvenile idiopathic arthritis. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S156.
  6. David JG, Langer DA, Kelso G, Lo MS. A181: evaluating decision-making in a pediatric rheumatology clinic. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S237.
  7. Son MB, Johnson VM, Hersh AO, Lo MS, Costenbader KH. Outcomes in hospitalized pediatric patients with systemic lupus erythematosus. Pediatrics. 2014 Jan; 133(1):e106-13.
  8. Lo MS, Zurakowski D, Son MB, Sundel RP. Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study. Pediatr Rheumatol Online J. 2013; 11(1):42.
  9. Lo MS, Lee GM, Gunawardane N, Burchett SK, Lachenauer CS, Lehmann LE. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant. 2013 Mar; 17(2):133-43.
  10. Hedrich CM, Crispin JC, Rauen T, Ioannidis C, Apostolidis SA, Lo MS, Kyttaris VC, Tsokos GC. cAMP response element modulator a controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc Natl Acad Sci U S A. 2012 Oct 9; 109(41):16606-11.
  11. Show all
  12. Lo MS, Tsokos GC. Treatment of systemic lupus erythematosus: new advances in targeted therapy. Ann N Y Acad Sci. 2012 Jan; 1247:138-52.
  13. Moulton VR, Lo MS, Tsokos GC. Methods and protocols to study T cell signaling abnormalities in human systemic lupus erythematosus. Methods Mol Biol. 2012; 900:25-60.
  14. Stutius LM, Pessach I, Lee J, Lo MS, Levy S, Schram P, Schizer M, Wong J, Phipatanakul W, Umetsu DT. Sublingual desensitization for buprenorphine hypersensitivity. J Allergy Clin Immunol. 2010 Apr; 125(4):938-9.
  15. Lo, MS, Gunawardane, ND, Lachenauer, CS, Lehmann, LE, Burchett, SK, Lee, GM . Respiratory viral infections in immunocompromised children. Pediatric Academic Societies. 2009.
  16. Zhang, Y, Takami, K, Lo, MS, Patel, AC, Huang, G, Yu, Q, Roswit, WT, Holtzman, MJ . Improved IFN efficacy and viral clearance by engineering a Super-Stat1 transgene. American Thoracic Society. 2007.
  17. Lo, MS. Anorexia Nervosa. Underground Clinical Vignettes: Pediatrics (edited by Kim S, Swanson T and Wasserman JD). 2007.
  18. Lo, MS. Varicella Zoster. Underground Clinical Vignettes: Pediatrics (edited by Kim S, Swanson T and Wasserman JD). 2007.
  19. Zhang Y, Takami K, Lo MS, Huang G, Yu Q, Roswit WT, Holtzman MJ. Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment. J Biol Chem. 2005 Oct 7; 280(40):34306-15.
  20. Lo MS, Brazas RM, Holtzman MJ. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol. 2005 Jul; 79(14):9315-9.
  21. Holtzman MJ, Tyner JW, Kim EY, Lo MS, Patel AC, Shornick LP, Agapov E, Zhang Y. Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 2(2):132-40.
  22. Holtzman MJ, Kim EY, Lo MS, Tyner JW, Shornick LP, Sumino KC, Zhang Y. Defining and adjusting divergent host responses to viral infection. Immunol Res. 2005; 32(1-3):123-41.
  23. Holtzman MJ, Morton JD, Shornick LP, Tyner JW, O'Sullivan MP, Antao A, Lo M, Castro M, Walter MJ. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol Rev. 2002 Jan; 82(1):19-46.
  24. Shornick LP, Briner D, Lo M, Holtzman MJ. Role of Stat1 in defense against respiratory viruses. Proceedings of Keystone Symposium: Molecular Aspects of Viral Immunity. 2001; 56.
  25. Lo M, Bloom ML, Imada K, Berg M, Bollenbacher JM, Bloom ET, Kelsall BL, Leonard WJ. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach. Blood. 1999 Nov 1; 94(9):3027-36.
To schedule an appointment: Call 617-355-6117

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close